Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

50 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Treatment with fluoroquinolones or with beta-lactam-beta-lactamase inhibitor combinations is a risk factor for isolation of extended-spectrum-beta-lactamase-producing Klebsiella species in hospitalized patients.
Wener KM, Schechner V, Gold HS, Wright SB, Carmeli Y. Wener KM, et al. Among authors: schechner v. Antimicrob Agents Chemother. 2010 May;54(5):2010-6. doi: 10.1128/AAC.01131-09. Epub 2010 Mar 8. Antimicrob Agents Chemother. 2010. PMID: 20211888 Free PMC article.
National multicenter study of predictors and outcomes of bacteremia upon hospital admission caused by Enterobacteriaceae producing extended-spectrum beta-lactamases.
Marchaim D, Gottesman T, Schwartz O, Korem M, Maor Y, Rahav G, Karplus R, Lazarovitch T, Braun E, Sprecher H, Lachish T, Wiener-Well Y, Alon D, Chowers M, Ciobotaro P, Bardenstein R, Paz A, Potasman I, Giladi M, Schechner V, Schwaber MJ, Klarfeld-Lidji S, Carmeli Y. Marchaim D, et al. Among authors: schechner v. Antimicrob Agents Chemother. 2010 Dec;54(12):5099-104. doi: 10.1128/AAC.00565-10. Epub 2010 Sep 13. Antimicrob Agents Chemother. 2010. PMID: 20837757 Free PMC article.
Pseudomonas aeruginosa bacteremia upon hospital admission: risk factors for mortality and influence of inadequate empirical antimicrobial therapy.
Schechner V, Gottesman T, Schwartz O, Korem M, Maor Y, Rahav G, Karplus R, Lazarovitch T, Braun E, Finkelstein R, Lachish T, Wiener-Well Y, Alon D, Chowers M, Bardenstein R, Zimhony O, Paz A, Potasman I, Giladi M, Schwaber MJ, Klarfeld-Lidji S, Hochman M, Marchaim D, Carmeli Y. Schechner V, et al. Diagn Microbiol Infect Dis. 2011 Sep;71(1):38-45. doi: 10.1016/j.diagmicrobio.2011.05.010. Epub 2011 Jul 16. Diagn Microbiol Infect Dis. 2011. PMID: 21763093
50 results